No picture, placeholder image
No picture, placeholder image
Institutt for samfunnsmedisin fsk004@uit.no +4777646401 +47 95 20 71 96 Her finner du meg

Finn Egil Skjeldestad


Professor


  • Finn Egil Skjeldestad, Sveinung Sørbye :
    May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
    International Journal of Environmental Research and Public Health (IJERPH) 2023 ARKIV / DOI
  • Finn Egil Skjeldestad :
    Minor changes in the incidence of primary and secondary involuntary childlessness across birth cohorts 1916 to 1975, but major differences in treatment success
    PLOS ONE 2023 ARKIV / DOI
  • Amir Rad, Sveinung Sørbye, Tormod Brenn, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad :
    13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up
    International Journal of Environmental Research and Public Health (IJERPH) 2023 ARKIV / DOI
  • Amir Rad, Sveinung Sørbye, Sweta Tiwari, Maja-Lisa Løchen, Finn Egil Skjeldestad :
    Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
    Cancers 2023 ARKIV / DOI
  • Torbjørn Moe Eggebø, Astrid Rygh, Brandis Philip Von, Finn Egil Skjeldestad :
    Prevention of obstetric anal sphincter injuries with perineal support and lateral episiotomy: A historical cohort study
    Acta Obstetricia et Gynecologica Scandinavica 2023 ARKIV / DOI
  • Ingela Lindh, Finn Egil Skjeldestad, Oskari Heikinheimo, Helena Hognert, Øjvind Lidegaard, Christina Bergh m.fl.:
    Reproductive changes among women in their 40s: A cross-sectional study
    Acta Obstetricia et Gynecologica Scandinavica 2022 ARKIV / DOI
  • Ingvild Hersoug Nedberg, Tinatin Manjavidze, Charlotta Rylander, Ellen Blix, Finn Egil Skjeldestad, Erik Eik Anda :
    Changes in cesarean section rates after introduction of a punitive financial policy in Georgia: A population-based registry study 2017-2019
    PLOS ONE 2022 ARKIV / DOI
  • Merethe Bjørkås, Finn Egil Skjeldestad :
    Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
    European Journal of Obstetrics, Gynecology, and Reproductive Biology 2022 ARKIV / DOI
  • Lina Grönvall, Finn Egil Skjeldestad :
    Changed definition of disease and broader screening criteria had little impact on prevalence of gestational diabetes mellitus
    Acta Obstetricia et Gynecologica Scandinavica 2021 ARKIV / DOI
  • Ingvild Hersoug Nedberg, Marzia Lazzerini, Ilaria Mariani, Kajsa Møllersen, Emanuelle Pessa Valente, Erik Eik Anda m.fl.:
    Changes in maternal risk factors and their association with changes in cesarean sections in Norway between 1999 and 2016: A descriptive population-based registry study
    PLoS Medicine 2021 ARKIV / DOI
  • Katherrine Ahrens, Finn Egil Skjeldestad :
    Trends in initiation of hormonal contraceptive methods among teenagers born between 1989 and 1997 in Norway and the United States
    Contraception 2021 ARKIV / DOI
  • Ingvild Hersoug Nedberg, Charlotta Rylander, Finn Egil Skjeldestad, Ellen Blix, Tamar Ugulava, Erik Eik Anda :
    Factors Associated with Cesarean Section among Primiparous Women in Georgia: A Registry-based Study
    Journal of Epidemiology and Global Health (JEGH) 2020 ARKIV / DOI
  • Tinatin Manjavidze, Charlotta Rylander, Finn Egil Skjeldestad, Nata Kazakhashvili, Erik Eik Anda :
    Unattended Pregnancies and Perinatal Mortality in Georgia
    Risk Mangement and Healthcare Policy 2020 ARKIV / DOI
  • Tinatin Manjavidze, Charlotta Rylander, Finn Egil Skjeldestad, Nata Kazakhashvili, Erik Eik Anda :
    The impact of antenatal care utilization on admissions to neonatal intensive care units and perinatal mortality in Georgia
    PLOS ONE 2020 ARKIV / DOI
  • Bjørn Holdø, Kajsa Møllersen, Margareta Verelst, Ian Milsom, Rune Svenningsen, Finn Egil Skjeldestad :
    Surgeon’s experience and clinical outcome after retropubic tension‐free vaginal tape—A case series
    Acta Obstetricia et Gynecologica Scandinavica 2020 ARKIV / DOI
  • Mathilde Seeger Bjørnerem, Sveinung Sørbye, Finn Egil Skjeldestad :
    Recurrent disease after treatment for cervical intraepithelial neoplasia-The importance of a flawless definition of residual disease and length of follow-up
    European Journal of Obstetrics, Gynecology, and Reproductive Biology 2020 ARKIV / DOI
  • Bjørn Holdø, Margareta Verelst, Rune Svenningsen, Ian Milsom, Finn Egil Skjeldestad :
    The retropubic tension-free vaginal tape procedure—Efficacy, risk factors for recurrence and long-term safety
    Acta Obstetricia et Gynecologica Scandinavica 2019 ARKIV / DOI
  • Tinatin Manjavidze, Charlotta Rylander, Finn Egil Skjeldestad, Nata Kazakhashvili, Erik Eik Anda :
    Incidence and causes of perinatal mortality in Georgia
    Journal of Epidemiology and Global Health (JEGH) 2019 ARKIV / DOI
  • Julie Ekman, Finn Egil Skjeldestad :
    Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
    BMJ Open 26. november 2019 ARKIV / DOI
  • Thomas Bergholt, Finn Egil Skjeldestad, Aura Pyykönen, Steen C. Rasmussen, Anna-Maija Tapper, Ragnheiður I. Bjarnadóttir m.fl.:
    Maternal age and risk of cesarean section in women with induced labor at term—A Nordic register‐based study
    Acta Obstetricia et Gynecologica Scandinavica 2019 ARKIV / DOI
  • Bjørn Westre, Anita Giske, Hilde Guttormsen, Sveinung Sørbye, Finn Egil Skjeldestad :
    Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study
    PLOS ONE 2019 FULLTEKST / ARKIV / DOI
  • Elisabeth Ludvigsen, Finn Egil Skjeldestad :
    Station of the fetal head at complete cervical dilation impacts duration of second stage of labor
    European Journal of Obstetrics and Gynecology and Reproductive Biology: X 31. oktober 2019 ARKIV / DOI
  • Janne Rossen, Kari Klungsøyr, Susanne Albrechtsen, Ellen Løkkegård, Steen Rasmussen, Thomas Bergholt m.fl.:
    Can oxytocin augmentation modify the risk of epidural analgesia by maternal age in cesarean sections?
    Acta Obstetricia et Gynecologica Scandinavica 2018 ARKIV / DOI
  • Ingvild Roksvaag, Finn Egil Skjeldestad :
    Decreasing trends in number of depot medroxyprogesterone acetate starters in Norway - a cross-sectional study
    Acta Obstetricia et Gynecologica Scandinavica 2018 ARKIV / DOI
  • Liv Reidun Tverelv, Sveinung Sørbye, Finn Egil Skjeldestad :
    Risk for cervical intraepithelial neoplasia grade 3 or higher in follow-up of women with a negative cervical biopsy
    Journal of Lower Genital Tract Disease 2018 DOI
  • Helena Hognert, Finn Egil Skjeldestad, Kristina Gemzell-Danielsson, Oskari Heikinheimo, Ian Milsom, Øjvind Lidegaard m.fl.:
    Ecological study on the use of hormonal contraception, abortions and births among teenagers in the Nordic countries
    BMJ Open 2018 ARKIV / DOI
  • Helena Hognert, Finn Egil Skjeldestad, Kristina Gemzell-Danielsson, Oskari Heikinheimo, Ian Milsom, Øjvind Lidegaard m.fl.:
    High birth rates despite easy access to contraception and abortion: a cross-sectional study
    Acta Obstetricia et Gynecologica Scandinavica 2017 DOI
  • Erik Eik Anda, Ingvild Hersoug Nedberg, Charlotta Rylander, Amiran Gamkrelidze, Alexander Turdziladze, Finn Egil Skjeldestad m.fl.:
    Implementing a birth registry in a developing country - experiences from Georgia
    Tidsskrift for Den norske legeforening 2017 DOI
  • Aura Pyykönen, Mika Gissler, Ellen Løkkegaard, Thomas Bergholt, Steen C. Rasmussen, Alexander Smárason m.fl.:
    Cesarean section trends in the Nordic Countries - a comparative analysis with the Robson classification
    Acta Obstetricia et Gynecologica Scandinavica 2017 DOI
  • Amir Rad, Sveinung Sørbye, Greta Dreyer, Siri Hovland, Bente Marie Falang, Melanie Louw m.fl.:
    HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests
    Medicine 05. desember 2017 ARKIV / FULLTEKST / DOI
  • Torbjørn Moe Eggebø, Astrid Rygh, Philip von Brandis, Finn Egil Skjeldestad :
    Langvarig nytte av det finske konsept for perineal støtte
    2023
  • Torbjørn Moe Eggebø, Astrid Rygh, P. von Brandis, Finn Egil Skjeldestad :
    Sammenhengen mellom sfinkterskade, episiotomi og risikofaktorer kjent før fødselen
    2023
  • Thomas Bergholt, Finn Egil Skjeldestad, Ellen Løkkegaard :
    Providing relevant information to pregnant women about induction of labor at term is essential. A Reply
    Acta Obstetricia et Gynecologica Scandinavica 2020 DOI
  • Sveinung Wergeland Sørbye, Finn Egil Skjeldestad :
    Importance of triage for HPV DNA positive women with a 7 HPV genotypes mRNA E6/E7 test
    2019
  • Finn Egil Skjeldestad :
    Lager p-pille som bare skal tas en gang i måneden.
    18. desember 2019
  • Finn Egil Skjeldestad :
    Vi mangler en aktiv prevensjonsdebatt i Norge.
    03. april 2019
  • Finn Egil Skjeldestad, Sveinung Wergeland Sørbye :
    Follow-up after treatment for CIN
    2019
  • Finn Egil Skjeldestad, Sveinung Wergeland Sørbye :
    Prevalence and HPV genotype distribution in cervical cancer
    2019
  • Finn Egil Skjeldestad :
    Det er tryggest å droppe mensen når du går på p-piller.
    29. mars 2019
  • Sveinung Wergeland Sørbye, Finn Egil Skjeldestad :
    Risk of CIN3+ in post-colposcopy follow-up of women with a negative cervical biopsy
    2019
  • Bjørn Holdø, Margareta Verelst, Rune Svenningsen, Iam Milsom, Finn Egil Skjeldestad :
    Tension-free vaginal tape – clinical outcomes and risk factors for recurrence
    2018
  • Finn Egil Skjeldestad, Julie Ekman :
    Prescribing COCs to starters - do gynecologists comply with guidelines?
    2018
  • Finn Egil Skjeldestad, Sveinung Wergeland Sørbye, Reidun Tverelv :
    Risk for CIN3+ in women with a negative cervical biopsy
    2018
  • Finn Egil Skjeldestad, Bjørn Westre, Anita Giske, Hilde Guttormsen, Sveinung Wergeland Sørbye :
    The added value of rescreening cytology normal samples with positive HPV mRNA test for the detection of CIN2+ in primary screening
    2018
  • Finn Egil Skjeldestad, Sveinung Wergeland Sørbye, Marte Slettebakk :
    HPV-test in triage of ASC-US / LSIL – The CIN3+ risk in 5-type HPV E6/E7 mRNA negative women
    2018
  • Sveinung Wergeland Sørbye, Liv Helen Hansen, Finn Egil Skjeldestad :
    Is con-testing with a 3-type HPV mRNA test better strategy for women 21-29 years than cytology alone?
    2018
  • Finn Egil Skjeldestad, Amir Rad, Sveinung Wergeland Sørbye, Siri Hovland :
    Primary cervical cancer screening with a 5-type HPV E6/E7 mRNA test: Results of 10 years follow-up
    2018
  • Finn Egil Skjeldestad, Sveinung W Sørbye, Marte Slettebakk :
    HPV-test in triage of ASC-US / LSIL - The CIN3+ risk in 5-type HPV E6/E7 mRNA. negative women
    2018
  • Sveinung Wergeland Sørbye, Liv Helen Hansen, Finn Egil Skjeldestad :
    A risk-based approach: Co-testing 34612 owmen with cytology and 3-type HPV mRNA test
    2018
  • Michael Bretthauer, Per Olav Vandvik, Finn Egil Skjeldestad, Jan C Frich, Thomas de Lange, Magnus Løberg :
    Ny spesialistutdanning for leger – fra sveitserost til kraftkar?
    Tidsskrift for Den norske legeforening 24. august 2017 DOI

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →


    Forskningsinteresser

    Informasjon vises på engelsk.